Viewing Study NCT05088967


Ignite Creation Date: 2025-12-25 @ 12:32 AM
Ignite Modification Date: 2026-02-02 @ 5:12 AM
Study NCT ID: NCT05088967
Status: TERMINATED
Last Update Posted: 2024-01-16
First Post: 2021-09-28
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of IBI110 in Combination With Sintilimab Versus Sintilimab Alone in Neoadjuvant and Adjuvant Therapy of Radically Resectable Non-small Cell Lung Cancer
Sponsor:
Organization: